Half-year report · Q2
9218.TEDINET S100U88E
Period2024-01-01 → 2024-06-30
Filed2024-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.3bn | 2024-01-01 → 2024-06-30 | Cons. | Net sales |
| Revenue | ¥2.6bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.3bn | 2023-01-01 → 2023-06-30 | Cons. | Net sales |
| Operating income | −¥96m | 2024-01-01 → 2024-06-30 | Cons. | Operating income |
| Operating income | ¥217m | 2023-01-01 → 2023-06-30 | Cons. | Operating income |
| Ordinary income | −¥147m | 2024-01-01 → 2024-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥496m | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥213m | 2023-01-01 → 2023-06-30 | Cons. | Ordinary income |
| Profit before tax | −¥146m | 2024-01-01 → 2024-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥219m | 2023-01-01 → 2023-06-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥202m | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥441m | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥158m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥202m | 2024-01-01 → 2024-06-30 | Cons. | Profit loss |
| Net income | ¥158m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss |
| Total assets | ¥4.3bn | at 2024-06-30 | Cons. | Assets |
| Total assets | ¥1.7bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥1.5bn | at 2023-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.2bn | at 2024-06-30 | Cons. | Liabilities |
| Total liabilities | ¥618m | at 2023-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.1bn | at 2024-06-30 | Cons. | Net assets |
| Net assets / equity | ¥1.1bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥823m | at 2023-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.1bn | at 2024-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥914m | at 2023-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.1bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥914m | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥812m | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥660m | at 2022-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥29m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥178m | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥18m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.9bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥91m | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥38m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥2.1bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥167m | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥209m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-20 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥44.29 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥41.78 | 2023-01-01 → 2023-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥14.96 | 2023-01-01 → 2023-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 21.4% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.3% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.6% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 39
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-06-30 | −¥26m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-06-30 | −¥26m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | −¥572m |
| jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥52m |
| jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥27m |
| jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥25m |
| jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥11m |
| jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥84m |
| jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥84m |
| jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥26m |
| jpcrp040300-q2r_E37508-000Medical Work Shift Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥939m |
| jpcrp040300-q2r_E37508-000Medical Work Shift Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥939m |
| jpcrp040300-q2r_E37508-000Medical Work Shift Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥109m |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥350,000 |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥330m |
| —segment total | revenue | 2024-01-01 → 2024-06-30 | ¥2.3bn |
| —segment total | revenue external | 2024-01-01 → 2024-06-30 | ¥2.3bn |
| —segment total | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥26m |
| —segment total | segment profit | 2024-01-01 → 2024-06-30 | ¥476m |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-06-30 | −¥53m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-06-30 | −¥53m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | −¥153m |
| jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥84m |
| jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥31m |
| jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥52m |
| jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥36m |
| jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥242m |
| jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥242m |
| jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥135m |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥1.0bn |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥1.0bn |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥450,000 |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥198m |
| —segment total | revenue | 2023-01-01 → 2023-06-30 | ¥1.4bn |
| —segment total | revenue external | 2023-01-01 → 2023-06-30 | ¥1.3bn |
| —segment total | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥53m |
| —segment total | segment profit | 2023-01-01 → 2023-06-30 | ¥369m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 520
| Item | Context | Value | Unit |
|---|---|---|---|
| Amortization of goodwill ope cf | Prior1YTDDuration | － | JPY |
| Amortization of goodwill ope cf | CurrentYTDDuration | 39383000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | Prior1YTDDuration | -132000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | CurrentYTDDuration | -606000 | JPY |
| Increase decrease in provision for bonuses ope cf | Prior1YTDDuration | － | JPY |
| Increase decrease in provision for bonuses ope cf | CurrentYTDDuration | 6280000 | JPY |
| Increase decrease in refund liabilities ope cf | Prior1YTDDuration | -1919000 | JPY |
| Increase decrease in refund liabilities ope cf | CurrentYTDDuration | 384000 | JPY |
| Interest income ope cf | Prior1YTDDuration | -3000 | JPY |
| Interest income ope cf | CurrentYTDDuration | -7000 | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 1770000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 13317000 | JPY |
| Compensation for damage income ope cf | Prior1YTDDuration | -5874000 | JPY |
| Compensation for damage income ope cf | CurrentYTDDuration | － | JPY |
| Share based compensation expenses ope cf | Prior1YTDDuration | － | JPY |
| Share based compensation expenses ope cf | CurrentYTDDuration | 191927000 | JPY |
| Share acquisition rights issuance costs ope cf | Prior1YTDDuration | 14000 | JPY |
| Share acquisition rights issuance costs ope cf | CurrentYTDDuration | 2038000 | JPY |
| Loss gain on sales of noncurrent assets ope cf | Prior1YTDDuration | － | JPY |
| Loss gain on sales of noncurrent assets ope cf | CurrentYTDDuration | 170000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | -26454000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | -20949000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | -126000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | -234000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | -47449000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | 8562000 | JPY |
| Decrease increase in prepaid expenses ope cf | Prior1YTDDuration | 13938000 | JPY |
| Decrease increase in prepaid expenses ope cf | CurrentYTDDuration | 4297000 | JPY |
| Decrease increase in consumption taxes refund receivable ope cf | Prior1YTDDuration | 1720000 | JPY |
| Decrease increase in consumption taxes refund receivable ope cf | CurrentYTDDuration | － | JPY |
| Decrease increase in accounts receivable other ope cf | Prior1YTDDuration | － | JPY |
| Decrease increase in accounts receivable other ope cf | CurrentYTDDuration | -2481000 | JPY |
| Increase decrease in accounts payable other ope cf | Prior1YTDDuration | -53153000 | JPY |
| Increase decrease in accounts payable other ope cf | CurrentYTDDuration | 66803000 | JPY |
| Increase decrease in contract liabilities ope cf | Prior1YTDDuration | -3030000 | JPY |
| Increase decrease in contract liabilities ope cf | CurrentYTDDuration | 7167000 | JPY |
| Increase decrease in accrued consumption taxes ope cf | Prior1YTDDuration | -18985000 | JPY |
| Increase decrease in accrued consumption taxes ope cf | CurrentYTDDuration | -34500000 | JPY |
| Increase decrease in deposits received ope cf | Prior1YTDDuration | － | JPY |
| Increase decrease in deposits received ope cf | CurrentYTDDuration | -74295000 | JPY |
| Decrease increase in long term prepaid expenses ope cf | Prior1YTDDuration | 753000 | JPY |
| Decrease increase in long term prepaid expenses ope cf | CurrentYTDDuration | 2694000 | JPY |
| Other net ope cf | Prior1YTDDuration | 19987000 | JPY |
| Other net ope cf | CurrentYTDDuration | 6157000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | 117926000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | 84217000 | JPY |
| Interest income received ope cf | Prior1YTDDuration | 3000 | JPY |
| Interest income received ope cf | CurrentYTDDuration | 7000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -1921000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -13218000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |